American Association of Individual Investors3d
Which Is a Better Investment, Glaukos Corporation or Inari Medical, Inc. Stock?
Learn more about whether Glaukos Corporation or Inari Medical, Inc. is a better investment based on AAII's A+ Investor grades ...
Ranking photographs Hornsea man as part of campaign to highlight preventable amputation
An Abbott-funded report, written by leading vascular experts from the NHS, found that the health service could save more than ...
Aplagon secures funding to support Phase IIa trial of APAC therapeutic
Finnish biopharmaceutical company Aplagon has secured a financing of €7m ($7.24m) to advance its heparin proteoglycan mimetic ...
Pharmabiz5d
Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials
Aplagon announces EUR 7 million financing to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2A trials: Helsinki Tuesday, February 4, 2025, 16:00 Hrs [IS ...
Endovascular Today5d
Cagent Vascular Launches Serranator SL-Pro for Chronic Limb-Threatening Ischemia and Pedal Disease
Cagent Vascular, Inc. announced the launch of its Serranator SL-Pro percutaneous transluminal angioplasty (PTA) serration ballo ...
PharmaTimes5d
Aplagon secures EUR 7 million for APAC phase 2a trials
Helsinki-based Aplagon has raised EUR 7 million to advance its APAC therapeutic for thrombo-inflammatory diseases into phase 2a clinical trials. Aki Prihti, CEO of Aplagon, said: “We’re delighted to ...